These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Altmann ES, Crossingham I, Wilson S, Davies HR. Cochrane Database Syst Rev; 2019 Oct 30; 2019(10):. PubMed ID: 31684683 [Abstract] [Full Text] [Related]
3. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema. Singh G, Pitoyo CW, Nasir AU, Rumende CM, Amin Z. Acta Med Indones; 2012 Jul 30; 44(3):258-64. PubMed ID: 22983084 [Abstract] [Full Text] [Related]
4. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Am J Respir Crit Care Med; 1997 Jan 30; 155(1):291-5. PubMed ID: 9001327 [Abstract] [Full Text] [Related]
5. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children]. Uyan AP, Ozyürek H, Yilmaz E. Tuberk Toraks; 2003 Jan 30; 51(3):320-4. PubMed ID: 15143413 [Abstract] [Full Text] [Related]
6. [Management of parapneumonic pleural effusions]. Asensio de la Cruz O, Blanco González J, Moreno Galdó A, Pérez Frías J, Salcedo Posadas A, Sanz Borrell L, Grupo de Trabajo de Técnicas Especiales en Neumología Pediátrica de la Sociedad Española de Neumología Pediátrica. An Esp Pediatr; 2001 Mar 30; 54(3):272-82. PubMed ID: 11262257 [Abstract] [Full Text] [Related]
7. The approach to the patient with a parapneumonic effusion. Wrightson JM, Davies RJ. Semin Respir Crit Care Med; 2010 Dec 30; 31(6):706-15. PubMed ID: 21213202 [Abstract] [Full Text] [Related]
9. Diagnosis and management of parapneumonic effusions and empyema. Sahn SA. Clin Infect Dis; 2007 Dec 01; 45(11):1480-6. PubMed ID: 17990232 [Abstract] [Full Text] [Related]
10. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cameron R, Davies HR. Cochrane Database Syst Rev; 2008 Apr 16; (2):CD002312. PubMed ID: 18425881 [Abstract] [Full Text] [Related]
11. [Parapneumonic effusion and pleural empyema--diagnosis and conservative therapy]. Wagner U, Vogelmeier C. Dtsch Med Wochenschr; 2005 Mar 11; 130(10):525-9. PubMed ID: 15744644 [No Abstract] [Full Text] [Related]
12. [Parapneumonic pleural effusions and empyema in adults:current practice]. Porcel JM, Light RW. Rev Clin Esp; 2009 Nov 11; 209(10):485-94. PubMed ID: 19889319 [Abstract] [Full Text] [Related]
13. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients. Israel EN, Blackmer AB. Pharmacotherapy; 2014 May 11; 34(5):521-32. PubMed ID: 24390857 [Abstract] [Full Text] [Related]
14. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study. Misthos P, Sepsas E, Konstantinou M, Athanassiadi K, Skottis I, Lioulias A. Eur J Cardiothorac Surg; 2005 Oct 11; 28(4):599-603. PubMed ID: 16129614 [Abstract] [Full Text] [Related]
15. New trends in the diagnosis and treatment in parapneumonic effusion and empyema. Na MJ, Dikensoy O, Light RW. Tuberk Toraks; 2008 Oct 11; 56(1):113-20. PubMed ID: 18330766 [Abstract] [Full Text] [Related]
16. Management of complicated parapneumonic effusions and thoracic empyema. Cameron RJ. Intern Med J; 2002 Aug 11; 32(8):408-14. PubMed ID: 12162398 [Abstract] [Full Text] [Related]